Cancer Gene Panels and Profiling Markets

$3,500.00

 

“Large Profile Panels are dominating the market.  Clinicians and Pharmaceutical customers building global demand and a new diagnostic industry based on Cancer Gene Sequencing.  What role will Whole Genome Sequencing eventually play?..."

564 Pages

Cancer Gene Panels and Genomic Profiling are quickly changing the diagnosis and treatment of cancers.  The market is moving out of a specialized niche and going mainstream as Oncologists begin routinely using information on the hundreds of genes related to cancer.  The market is exploding as physicians use all the information they can get in the battle against cancer. While Pharmaceutical Companies see the potential to make nearly any therapy viable.  The report has data on how test volumes have grown for the biggest players.  Find out how this new way of understanding cancer will change cancer diagnostics forever.

Comprehensive panels, genomic profiling, high risk breast cancer panels.  Learn all about how players are jockeying for position in a market that is being created from scratch.  And some players are pulling way out in front and expanding globally.  It is a dynamic market situation with enormous opportunity where the right diagnostic with the right support can command premium pricing.  And the science is developing at the same time creating new opportunities with regularity.  And the cost of sequencing continues to fall. 

 " Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Screening potential market size, customized forecasting/analysis, and Executive and Consultant Guides 2021-2025" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2021 United States Medicare Fee Payment Schedules to help understand test pricing in detail.   Forecast demand for new testing regimes or technologies.  Make research investment decisions.  Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges.  Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.  Again, assistance in using the information is normally provided without additional charges. 

 The report includes detailed breakouts for 18 Countries and 4 Regions.  A detailed breakout for any country in the world is available to purchasers of the report.

See the Table of Contents.

Send an email to us at service@howesoundresearch.com and we will happily email you a FREE copy of SAMPLE PAGES FROM THIS REPORT without any obligation on your part.  And we will not pester you with phone calls!

Make investment decisions and valuations with confidence using the latest data.  

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. 

 

He is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

B.Sc. (Chemistry) University of BC

M.B.A. (Finance and Policy) University of BC

Market Research  - Burke Institute

Finance for Senior Executives - Harvard Business School

Related products